- Home
- CLPR vs ELUT Comparison
CLPR vs ELUT Comparison
Compare CLPR & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPR | ELUT |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 48.3M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CLPR | ELUT |
|---|---|---|
| Price | $3.11 | $1.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 72.8K | ★ 88.5K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.73% | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,997,000.00 | $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.82 | N/A |
| 52 Week Low | $2.83 | $0.50 |
| 52 Week High | $4.61 | $2.60 |
Technical Indicators
Market Signals| Indicator | CLPR | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 46.97 | 45.27 |
| Support Level | $2.88 | $0.87 |
| Resistance Level | $3.28 | $0.99 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 25.81 | 29.41 |
Price Performance
Historical ComparisonAbout CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.